Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

64.41
Delayed Data
As of Apr 24
 +1.16 / +1.83%
Today’s Change
47.36
Today|||52-Week Range
68.75
+12.00%
Year-to-Date
Are Biosimilars the Next Big Thing in Biotech?
Apr 25 / MotleyFool.com
Mylan Shares Jump On $40 Billion Bid From Teva Pharmaceutical
Apr 21 / Benzinga
Teva-Active Biotech Start Phase II on MS Drug - Analyst Blog
Apr 24 / Zacks.com
Teva Makes $40.1B Bid for Generic-Drug Rival Mylan, Proving Rumors Right
Apr 21 / TheStreet.com
Partnerships Lift Small Caps
Apr 24 / TheStreet.com
Morning Market Losers
Apr 21 / Benzinga
Will Biogen's (BIIB) Earnings Streak Continue in 1Q? - Analyst Blog
Apr 23 / Zacks.com
Morning Market Gainers
Apr 21 / Benzinga
Benzinga's M&A Chatter for Wednesday April 22, 2015
Apr 22 / Benzinga
Stocks Are Mixed as DuPont and Verizon Drag on the Dow
Apr 21 / TheStreet.com
Teva Proposes to Buy Mylan, Sends Shares Up - Analyst Blog
Apr 22 / Zacks.com
Benzinga's Top #PreMarket Losers
Apr 21 / Benzinga
Surprising stocks push Nasdaq closer to record
Apr 22 / CNNMoney.com
Benzinga's Top #PreMarket Gainers
Apr 21 / Benzinga
Stock Market News for April 22, 2015 - Market News
Apr 22 / Zacks.com
Teva Pharmaceutical Industries (TEVA) Leads The Pack In Pre-Market Activity
Apr 21 / TheStreet.com
Teva Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Mylan
Apr 22 / Benzinga
Teva Pharmaceutical (TEVA) Stock Soaring in Pre-Market Trading Today on Mylan Takeove...
Apr 21 / TheStreet.com
Teva Won't Let Regulators, Poison Pill Stop Its Quest for Mylan
Apr 22 / TheStreet.com
Teva Pharmaceuticals (TEVA) Stock Declines Today on Generic Copaxone Approval
Apr 20 / TheStreet.com
Perrigo Beats on Q3 Earnings, Gives View, Rejects Mylan Bid - Analyst Blog
Apr 22 / Zacks.com
Mylan Says a Teva Pharmaceutical Merger Wouldn't Make Sense
Apr 20 / TheStreet.com
Japanese Stocks Hit 15-Year High
Apr 22 / TheStreet.com
Benzinga's Weekend M&A Chatter
Apr 19 / Benzinga
Benzinga's M&A Chatter for Tuesday April 21, 2015
Apr 21 / Benzinga
3 Top Healthcare Stocks Surging Higher This Year
Apr 18 / MotleyFool.com
Market Wrap: Major Indexes End Mixed
Apr 21 / TheStreet.com
Novartis and Momenta Get FDA Nod For Generic Copaxone - Analyst Blog
Apr 17 / Zacks.com
Why Mylan NV Is Suddenly in the Driver's Seat
Apr 21 / MotleyFool.com
VIVUS Responds to Teva's Filing for Qsymia Generics - Analyst Blog
Apr 16 / Zacks.com
Deal or No Deal, Stick With Mylan
Apr 21 / TheStreet.com
Why Momenta Pharmaceuticals Inc. Shares Are Surging Higher
Apr 16 / MotleyFool.com
Deal or No Deal, Stick With Mylan
Apr 21 / TheStreet.com
Mylan Settles Patent Litigation Related to Pfizer's Viagra - Analyst Blog
Apr 14 / Zacks.com
Benzinga's Volume Movers
Apr 21 / Benzinga
Inside The Surging Israel ETFs - ETF News And Commentary
Apr 14 / Zacks.com
Stocks Hitting 52-Week Highs
Apr 21 / Benzinga
 

To view my watchlist

Not a member yet?

Sign up now for a free account